{
    "eid": "2-s2.0-84944725642",
    "title": "Prevention of Recurrent Pterygium with Topical Bevacizumab 0.05% Eye Drops: A Randomized Controlled Trial",
    "cover-date": "2015-10-01",
    "subject-areas": [
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        }
    ],
    "keywords": [
        "antivascular endothelial growth factor",
        "bevacizumab",
        "pterygium",
        "pterygium surgery",
        "recurrence pterygium"
    ],
    "authors": [
        "Ngamjit Kasetsuwan"
    ],
    "citedby-count": 24,
    "ref-count": 22,
    "ref-list": [
        "Current concepts and techniques in pterygium treatment",
        "Options and adjuvants in surgery for pterygium: A report by the American academy of ophthalmology",
        "Pterygia: Pathogenesis and the role of subconjunctival bevacizumab in treatment",
        "Bevacizumab: An angiogenesis inhibitor for the treatment of solid malignancies",
        "Short- and long-term safety profile and efficacy of topical bevacizumab (Avastin\u00ae) eye drops against corneal neovascularization",
        "Comparison of conjunctival autografts amniotic membrane grafts, and primary closure for pterygium excision",
        "Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-\u03b2 and tumor necrosis factor-\u03b1 in the pterygium",
        "Vascular endothelial growth factor and its receptor system: Physiological functions in angiogenesis and pathological roles in various diseases",
        "Pathogenetic mechanisms and treatment options for ophthalmic pterygium: Trends and perspectives (review)",
        "Corneal angiogenesis and lymphangiogenesis",
        "Overexpression of vascular endothelial growth factor receptor 2 in pterygia may have a predictive value for a higher postoperative recurrence rate",
        "Efficacy of intralesional bevacizumab injection in decreasing pterygium size",
        "A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: Preliminary results",
        "Subconjunctival bevacizumab injection in treatment of pterygium",
        "Effect of subconjunctival bevacizumab on primary pterygium",
        "Preliminary results of subconjunctival bevacizumab in primary pterygium excision",
        "Subconjunctival bevacizumab immediately after excision of primary pterygium: The first clinical trial",
        "Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision",
        "Expression of vascular endothelial growth factor C in human pterygium",
        "Comparative evaluation of lymphatic vessels in primary versus recurrent pterygium",
        "Thrombospondin 1 inhibits inflammatory lymphangiogenesis by CD36 ligation on monocytes",
        "Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Asia Research Center",
        "Chulalongkorn University"
    ]
}